SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-20-289213
Filing Date
2020-11-09
Accepted
2020-11-09 17:09:21
Documents
64
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d55966d10q.htm   iXBRL 10-Q 1265817
2 EX-31.1 d55966dex311.htm EX-31.1 10328
3 EX-31.2 d55966dex312.htm EX-31.2 10314
4 EX-32.1 d55966dex321.htm EX-32.1 4383
5 EX-32.2 d55966dex322.htm EX-32.2 4296
  Complete submission text file 0001193125-20-289213.txt   5287426

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA cprx-20200930.xsd EX-101.SCH 40226
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cprx-20200930_cal.xml EX-101.CAL 40424
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cprx-20200930_def.xml EX-101.DEF 146285
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE cprx-20200930_lab.xml EX-101.LAB 320602
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cprx-20200930_pre.xml EX-101.PRE 248802
11 EXTRACTED XBRL INSTANCE DOCUMENT d55966d10q_htm.xml XML 892081
Mailing Address 355 ALHAMBRA CIRCLE SUITE 1250 CORAL GABLES FL 33134
Business Address 355 ALHAMBRA CIRCLE SUITE 1250 CORAL GABLES FL 33134 (305) 529-2522
CATALYST PHARMACEUTICALS, INC. (Filer) CIK: 0001369568 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33057 | Film No.: 201298669
SIC: 2834 Pharmaceutical Preparations